作者：
Siegel, David S. [1]
;
Weisel, Katja C. [2]
;
Dimopoulos, Meletios A. [3]
;
Baz, Rachid [4]
;
Richardson, Paul [5]
;
Delforge, Michel [6]
;
Song, Kevin W. [7]
;
San Miguel, Jesus F. [8]
;
Moreau, Philippe [9]
;
Goldschmidt, Hartmut [10]
;
Cavo, Michele [11]
;
Jagannath, Sundar [12]
;
Yu, Xin [13]
;
Hong, Kevin [14]
;
Sternas, Lars ;
Zaki, Mohamed ;
Palumbo, Antonio
作者单位：
CHU Nantes, CHU Hotel Dieu, Dept Hematol, Nantes, France
[1]
Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Div Multiple Myeloma, Hackensack, NJ USA
[2]
Univ Hosp Leuven, Dept Hematol, Leuven, Belgium
[3]
Univ Athens, Sch Med, Dept Clin Therapeut Univ, Athens, Greece
[4]
Heidelberg Univ, Dept Med 5, Heidelberg, Germany
[5]
Vancouver Gen Hosp, Div Hematol, Vancouver, BC, Canada
[6]
Mt Sinai Hosp, Tisch Canc Inst, New York, NY 10029 USA
[7]
Univ Tubingen Hosp, Dept Hematol Oncol Immunol Rheumatol & Pulm, Tubingen, Germany
[8]
Dana Farber Canc Inst, Myeloma Program, Boston, MA 02115 USA
[9]
Univ Navarra Clin, CIMA, IDISNA, Clin & Translat Med, Pamplona, Spain
[10]
Celgene Corp, Summit, NJ USA
[11]
Univ Turin, Dept Hematol, Turin, Italy
[12]
H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[13]
Univ Bologna, Sch Med, Seragnoli Inst Hematol, Bologna, Italy
[14]
发布时间
2017-04-06
换一批
换一批
